Anavex Life Sciences Corp (AVXL)

[JoeBear906]

Who are we shareholders? Nobody. There is one reality that affect share price in the near term: Approval of Blarcamesine in the EU. Any convincing in the near term will be in the form of a voluminous EMA NDA (12 component process) or whatever they call an NDA. We shareholders long or short are meaningless. He has 5 years of runway cash. Figuratively, TGD has a breakaway shot on goal, and that is all he should do. Convincing Adam Feuerstein of anything is impossible. Feeding data to Big Pharma or the BP captured FDA is dangerous to his IP. Talking the FUD patrol off the wall impossible. Convincing the shorts of Anavex's inherent intrinsic value is a waste of his precious time and utterly pointless as shorts exist only to feed off the downstroke and this engine will always have a downstroke.
I would like progress reports on the submittal portions of the NDA's 12 components and innocuous PR's on RETT's and other drug's new trials. I don't even think peer reviewed articles are important enough to push. Nell has a hell of a lot of typing to do.